A detailed history of Heritage Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Heritage Trust CO holds 8,384 shares of BMY stock, worth $476,546. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,384
Previous 8,488 1.23%
Holding current value
$476,546
Previous $460,000 24.35%
% of portfolio
0.05%
Previous 0.06%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $4,186 - $5,510
-104 Reduced 1.23%
8,384 $348,000
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $91,066 - $103,251
-1,898 Reduced 18.27%
8,488 $460,000
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $1.35 Million - $1.61 Million
-27,889 Reduced 72.86%
10,386 $532,000
Q3 2023

Nov 08, 2023

SELL
$57.89 - $64.73 $2,720 - $3,042
-47 Reduced 0.12%
38,275 $2.22 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $161,950 - $179,821
2,542 Added 7.1%
38,322 $2.45 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $175,379 - $198,920
2,669 Added 8.06%
35,780 $2.48 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $264,058 - $312,683
3,856 Added 13.18%
33,111 $2.38 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $2 - $1,229
-16 Reduced 0.05%
29,255 $2.08 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $41,756 - $45,988
575 Added 2.0%
29,271 $2.25 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $1.19 Million - $1.43 Million
19,406 Added 208.89%
28,696 $2.1 Million
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $30,998 - $36,136
578 Added 6.63%
9,290 $579,000
Q3 2021

Nov 09, 2021

BUY
$59.17 - $69.31 $11,123 - $13,030
188 Added 2.21%
8,712 $516,000
Q2 2021

Aug 09, 2021

BUY
$61.91 - $67.42 $54,790 - $59,666
885 Added 11.59%
8,524 $570,000
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $384,997 - $433,009
-6,488 Reduced 45.93%
7,639 $482,000
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $17,379 - $19,694
301 Added 2.18%
14,127 $876,000
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $141,966 - $157,318
-2,472 Reduced 15.17%
13,826 $833,000
Q2 2020

Aug 04, 2020

BUY
$54.82 - $64.09 $493,708 - $577,194
9,006 Added 123.51%
16,298 $958,000
Q1 2020

May 11, 2020

BUY
$46.4 - $67.43 $278 - $404
6 Added 0.08%
7,292 $406,000
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $358,544 - $467,688
7,286 New
7,286 $468,000
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $67,680 - $80,700
-1,500 Closed
0 $0
Q4 2018

Jan 18, 2019

SELL
$48.76 - $63.23 $9,410 - $12,203
-193 Reduced 11.4%
1,500 $78,000
Q2 2018

Aug 15, 2018

SELL
$50.53 - $62.98 $9,600 - $11,966
-190 Reduced 10.09%
1,693 $94,000
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $839 - $914
-14 Reduced 0.74%
1,883 $115,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $104,771 - $120,914
1,897
1,897 $121,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Heritage Trust CO Portfolio

Follow Heritage Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Trust CO with notifications on news.